<DOC>
	<DOCNO>NCT01062165</DOCNO>
	<brief_summary>This study find weight affect dose drug call caspofungin . Currently , amount caspofungin patient receive regardless patient 's weight .</brief_summary>
	<brief_title>Effect Weight and/or Obesity Caspofungin Drug Concentrations</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Male female subject , age 18 year age old , racial ethnic origin . English and/or Spanish speaking volunteer eligible participate . Pregnant nursing unwilling use reliable contraception method study . The effect caspofungin pregnancy unknown . In addition , metabolic change accompany pregnancy may alter concentrationtime profile caspofungin , pregnancy postpartum state would confound variable . Abnormal liver function test : transaminase &gt; 10 time upper limit normal , Alkaline phosphatase &gt; 5 time upper limit normal , total bilirubin &gt; 5 time upper limit normal . History allergies echinocandins . Echinocandins contraindicate reason . Volunteers unwilling comply study procedure . Suspected documented systemic fungal infection . Concomitant use rifamycins , tacrolimus , cyclosporine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Echinocandin</keyword>
	<keyword>Obesity</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Fungal infection</keyword>
</DOC>